What is immobility
costing your facility?

How we calculate these Numbers.

Estimates are derived from published clinical literature on immobility-related complications and their associated costs. Each category represents an evidence-based cost driver that structured in-bed mobility has been shown to influence.

Sources include Kortebein et al. (JAMA), Creditor HE (NEJM), Brown CJ et al. (JAGS), and institutional data from pilot deployments. Individual facility results will vary based on patient acuity, case mix, and baseline mobility programs.

• Length of Stay

  The largest savings category. Based on published associations between structured mobility and average patient days.

• Falls

  Per-event cost estimates from published fall injury data. Immobility-related weakness is a documented associated factor.

• Delirium

  Published literature associates immobility with delirium incidence. Extended stays and additional interventions drive costs.

• Readmissions

  CMS penalty category. Objective discharge data supports more informed readiness assessments.

• DVT

  Prolonged immobility is an established associated factor in venous complications. Per-event costs from published data.

• Post-Acute Discharges

  SNF vs. home discharge cost differentials. Objective mobility data supports more informed pathway decisions.